Colorectal cancer screening is one of the few areas in this whole "at-home gut test" aisle where the underlying test is part of mainstream medical guidelines. A fecal immunochemical test, or FIT, checks a stool sample for traces of blood you can't see. Some FIT kits are now cleared by the FDA for over-the-counter use and sold on Amazon, where you read the result yourself in a few minutes.
That convenience is real, and so are the limits. This guide covers what a FIT does, how accurate it is, who it's meant for, the two kits we'd buy, a kit we deliberately left out, and what a positive result means.
This article is for general education and isn't a substitute for advice from your own doctor about when and how you should be screened.
Quick Answer
An at-home FIT checks a stool sample for hidden human blood. Done every year, it's one of the colorectal cancer screening options accepted for average-risk adults aged 45 to 75 without symptoms. A single test catches about 4 in 5 cancers, so repeat it yearly, and follow any positive result with a colonoscopy.
What a FIT Kit Actually Checks
Colorectal cancers and some large polyps can bleed in small amounts, often long before anyone would notice. A FIT uses antibodies that bind to human hemoglobin, the protein in red blood cells, to detect that hidden blood in a stool sample.
Because the antibodies are specific to human hemoglobin, the test doesn't react to red meat in your diet. That's the main practical difference from older guaiac-based stool tests, which came with diet restrictions.
What a FIT does not do is look for cancer directly. It flags blood. A positive result tells you something in your lower digestive tract is bleeding and needs a look. A negative result means no blood was detected in that sample on that day.
Who Should, and Shouldn't, Use a Home FIT
The US Preventive Services Task Force recommends colorectal cancer screening for all adults aged 50 to 75 (an A recommendation) and for adults aged 45 to 49 (a B recommendation). It recommends that clinicians selectively offer screening to adults aged 76 to 85, based on their health and screening history PMID: 34003218.
Those recommendations apply to people at average risk who have no symptoms. The task force defines average risk as having no prior colorectal cancer, adenomatous polyps or inflammatory bowel disease, and no known inherited syndrome such as Lynch syndrome PMID: 34003218. A yearly FIT is one of several screening strategies it accepts for that group.
A home FIT is not the right tool if any of these apply. See a doctor instead:
- Blood in or on your stool, or black, tarry stools
- A persistent change in bowel habits, unexplained weight loss, or iron-deficiency anemia
- A personal history of colorectal cancer, advanced polyps, or inflammatory bowel disease
- A family history of colorectal cancer, especially in a parent, sibling or child, or a known hereditary cancer syndrome
In those situations a negative home test can be falsely reassuring, and you likely need a colonoscopy or a different screening schedule.
How Accurate Is a FIT?
The best single summary of FIT accuracy is a 2014 meta-analysis of 19 studies. It found FITs detected about 79% of colorectal cancers (pooled sensitivity 0.79) and correctly returned a negative result in about 94% of people without cancer (pooled specificity 0.94). Tests with lower positivity thresholds caught more cancers, and a single stool sample performed about as well as multiple samples PMID: 24658694.
In plain terms, a single FIT will miss roughly 1 in 5 cancers, and some people without cancer will get a positive result that turns out to be something else. FIT is less good at picking up precancerous polyps than cancer. That's why FIT screening only works as a yearly habit: repeating the test catches bleeding that a previous sample missed.
One caveat matters for home kits. The accuracy evidence comes from FITs in general, mostly tests ordered by clinicians and read in labs. The over-the-counter kits below use the same antibody principle and are FDA-cleared, but we didn't find published screening studies of these specific brands.
Treat marketing numbers carefully, too. Reese's ColoTest, for example, advertises that it is "98.8% accurate." A lab accuracy figure for detecting blood in a sample is not the same thing as how often a test catches cancer in real screening, which is the 79% figure above.
Home FIT Kits Compared
| Colonox FIT (Diagnox) | Reese's ColoTest | FIT ordered by your doctor | |
|---|---|---|---|
| How it's read | At home: lines on a test cassette | At home: lines on a test cassette | In a lab; result goes to your clinician |
| Time to result | 10 minutes | About 1 to 2 minutes | Days, including mailing |
| Regulatory status | FDA-cleared for home use; CLIA-waived | FDA-cleared over the counter (2023) | Lab test ordered by a clinician |
| Stated detection threshold | 45 ng/mL hemoglobin | Not listed in the brand's FAQ | Set by the lab |
| Tests per box | 1, 2 or 3 | 1 | 1 per order |
| Price on Amazon | $13.97 (1) / $19.97 (2) / $24.97 (3) | $16.50 | Usually covered as preventive screening; check your plan |
| Ends up in your medical record | Only if you tell your doctor | Only if you tell your doctor | Yes |
The Kits We'd Buy
Both picks below are FDA-cleared, in stock on Amazon, and sold by the manufacturer itself rather than a third-party reseller, as of September 2026.
Colonox FIT by Diagnox: best for yearly screening
Diagnox publishes a detection threshold of 45 ng/mL of hemoglobin, which many brands don't. The test is CLIA-waived and cleared for home use. The multi-test boxes are the practical draw: FIT only works when repeated, and a two- or three-test box costs less per test than buying single kits each year. Results take 10 minutes.
We earn 1-4.5%/sale if you buy · See all commissions
Reese's ColoTest: fastest result
ColoTest was cleared by the FDA for over-the-counter use in 2023 and gives a result in a minute or two. It comes as a single test and needs no diet changes. Its brand FAQ doesn't list a detection threshold, and its "98.8% accurate" claim should be read as described above, not as a cancer-detection rate.
We earn 1-4.5%/sale if you buy · See all commissions
The Kit We Left Out
Pinnacle BioLabs' Second Generation FIT is one of the most visible FIT brands on Amazon. In April 2024 the FDA sent Pinnacle BioLabs a warning letter. The letter said the company was marketing a repackaged fecal occult blood test for colorectal cancer screening without the required FDA clearance for that use. It also cited quality-system problems. We don't recommend a medical screening test with that record when cleared alternatives cost about the same.
We also skipped unbranded or generic "colon test" listings where we couldn't confirm who makes the test or whether it's FDA-cleared.
If Your Result Is Positive
A positive FIT is not a cancer diagnosis. Hemorrhoids, fissures, inflammation and polyps can all cause blood in the stool. But a positive result always needs follow-up, and that follow-up is a colonoscopy, not a second home kit.
Timing matters. A systematic review of studies on this question found consistent links between longer waits and worse outcomes. In the two largest studies, colonoscopy more than 9 months after a positive FIT, compared with within 1 month, was associated with higher odds of colorectal cancer and of advanced-stage cancer at diagnosis. The authors concluded colonoscopy after a positive FIT should not be delayed beyond 9 months, and ideally should happen well before that PMID: 33010414.
So if your kit is positive, call your doctor that week, tell them you had a positive home FIT, and get the colonoscopy scheduled.
Why a Home Kit Shouldn't Replace Your Doctor's Screening Plan
A home FIT is a good option if the realistic alternative is not being screened at all. But it has gaps that a clinician-ordered test doesn't:
- No record. Your result doesn't reach your medical record unless you report it, so no one tracks whether you screened last year or follow up a positive result.
- No reminders. Yearly FIT only protects you if you actually repeat it every year.
- Insurance. Screening tests ordered through your clinician are usually covered as preventive care, so a lab FIT or colonoscopy may cost you nothing out of pocket.
- Other options. Colonoscopy, stool DNA tests such as Cologuard, and CT colonography are also accepted screening strategies, each with its own interval PMID: 34003218. Your doctor can help you pick the one you'll actually stick with.
If you use a home kit, tell your doctor the date and the result at your next visit.
For stool tests that look at your gut bacteria rather than hidden blood, see our at-home gut test comparison. Those are wellness products, not cancer screening.
Frequently Asked Questions
Are at-home colon cancer tests accurate? Reasonably, but not perfectly. A single FIT detects about 79% of colorectal cancers and is correctly negative in about 94% of people without cancer, which is why it's repeated every year PMID: 24658694. That evidence is for FITs in general, not any specific home brand.
Who should use an at-home FIT kit? Average-risk adults aged 45 to 75 without symptoms. People aged 76 to 85 should decide with their doctor. Anyone with symptoms or a high-risk history should see a doctor instead.
What should I do if my home FIT is positive? Arrange a colonoscopy through your doctor promptly. Don't retest hoping for a negative result.
Can a FIT kit replace a colonoscopy? For average-risk people without symptoms, yearly FIT is an accepted screening option. It isn't a replacement if you have symptoms or high risk, and a positive FIT always needs a colonoscopy.
Is a FIT kit the same as Cologuard? No. Cologuard is a prescription, lab-analyzed stool DNA test. An over-the-counter FIT only checks for hidden blood.
Do I need to change my diet before a FIT? Generally no, because FITs detect human hemoglobin specifically. Follow your kit's instructions, and don't collect a sample during a menstrual period or while hemorrhoids are bleeding.
References
- US Preventive Services Task Force, Davidson KW, Barry MJ, et al. Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2021;325(19):1965-1977. PMID: 34003218.
- Lee JK, Liles EG, Bent S, et al. Accuracy of fecal immunochemical tests for colorectal cancer: systematic review and meta-analysis. Annals of Internal Medicine. 2014;160(3):171. PMID: 24658694.
- Forbes N, Hilsden RJ, Martel M, et al. Association Between Time to Colonoscopy After Positive Fecal Testing and Colorectal Cancer Outcomes: A Systematic Review. Clinical Gastroenterology and Hepatology. 2021;19(7):1344-1354.e8. PMID: 33010414.